BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28479376)

  • 1. Extracellular Vesicles in Bile as Markers of Malignant Biliary Stenoses.
    Severino V; Dumonceau JM; Delhaye M; Moll S; Annessi-Ramseyer I; Robin X; Frossard JL; Farina A
    Gastroenterology; 2017 Aug; 153(2):495-504.e8. PubMed ID: 28479376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses.
    Farina A; Dumonceau JM; Antinori P; Annessi-Ramseyer I; Frossard JL; Hochstrasser DF; Delhaye M; Lescuyer P
    Biochim Biophys Acta; 2014 May; 1844(5):1018-25. PubMed ID: 23806607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis.
    Alvaro D; Macarri G; Mancino MG; Marzioni M; Bragazzi M; Onori P; Corradini SG; Invernizzi P; Franchitto A; Attili AF; Gaudio E; Benedetti A
    Ann Intern Med; 2007 Oct; 147(7):451-9. PubMed ID: 17909206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated approach for comparative proteomic analysis of human bile reveals overexpressed cancer-associated proteins in malignant biliary stenosis.
    Lukic N; Visentin R; Delhaye M; Frossard JL; Lescuyer P; Dumonceau JM; Farina A
    Biochim Biophys Acta; 2014 May; 1844(5):1026-33. PubMed ID: 23872482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: results of a prospective, single-blind, comparative study.
    Weilert F; Bhat YM; Binmoeller KF; Kane S; Jaffee IM; Shaw RE; Cameron R; Hashimoto Y; Shah JN
    Gastrointest Endosc; 2014 Jul; 80(1):97-104. PubMed ID: 24559784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions.
    Ince AT; Yıldız K; Baysal B; Danalıoğlu A; Kocaman O; Tozlu M; Gangarapu V; Sarbay Kemik A; Uysal Ö; Şentürk H
    Turk J Gastroenterol; 2014 Apr; 25(2):162-9. PubMed ID: 25003676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease.
    Zabron AA; Horneffer-van der Sluis VM; Wadsworth CA; Laird F; Gierula M; Thillainayagam AV; Vlavianos P; Westaby D; Taylor-Robinson SD; Edwards RJ; Khan SA
    Am J Gastroenterol; 2011 Sep; 106(9):1711-7. PubMed ID: 21670771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple-tissue sampling during endoscopic retrograde cholangiopancreatography increases the overall diagnostic sensitivity for cholangiocarcinoma.
    Lee SJ; Lee YS; Lee MG; Lee SH; Shin E; Hwang JH
    Gut Liver; 2014 Nov; 8(6):669-73. PubMed ID: 25368755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic value of exosomal miRNAs in human bile of malignant biliary obstructions.
    Ge X; Tang L; Wang Y; Wang N; Zhou J; Deng X; Zhong Y; Li Q; Wang F; Jiang G; Miao L
    Dig Liver Dis; 2021 Jun; 53(6):760-765. PubMed ID: 33257140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brush cytology in malignant biliary obstruction.
    Singh V; Bhasin S; Nain CK; Gupta SK; Singh G; Bose SM
    Indian J Pathol Microbiol; 2003 Apr; 46(2):197-200. PubMed ID: 15022908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital, single-operator cholangiopancreatoscopy in the diagnosis and management of pancreatobiliary disorders: a multicenter clinical experience (with video).
    Navaneethan U; Hasan MK; Kommaraju K; Zhu X; Hebert-Magee S; Hawes RH; Vargo JJ; Varadarajulu S; Parsi MA
    Gastrointest Endosc; 2016 Oct; 84(4):649-55. PubMed ID: 26995690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transpapillary biliary biopsy for malignant biliary strictures: comparison between cholangiocarcinoma and pancreatic cancer.
    Chen WM; Wei KL; Chen YS; Chang PJ; Tung SY; Chang TS; Huang HC; Shen CH; Hsieh YY; Wu CS
    World J Surg Oncol; 2016 May; 14():140. PubMed ID: 27142076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.
    Tischendorf JJ; Krüger M; Trautwein C; Duckstein N; Schneider A; Manns MP; Meier PN
    Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
    Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
    Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of a new endoscopic scraper for malignant biliary strictures: a multicenter prospective study.
    Sakuma Y; Kodama Y; Sogabe Y; Nakai Y; Yamashita Y; Mikami S; Kajimura K; Ikeda K; Tamaki H; Iwamoto S; Matsuda F; Fujita K; Uza N; Kawamura T; Uemoto S; Seno H; Chiba T; Yazumi S;
    Gastrointest Endosc; 2017 Feb; 85(2):371-379. PubMed ID: 27497604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is endoscopic drainage of common bile duct stenoses in chronic pancreatitis up-to-date?
    Farnbacher MJ; Rabenstein T; Ell C; Hahn EG; Schneider HT
    Am J Gastroenterol; 2000 Jun; 95(6):1466-71. PubMed ID: 10894580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer.
    Farina A; Dumonceau JM; Frossard JL; Hadengue A; Hochstrasser DF; Lescuyer P
    J Proteome Res; 2009 Jan; 8(1):159-69. PubMed ID: 19055478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a phase I-II study on intraductal confocal microscopy (IDCM) in patients with common bile duct (CBD) stenosis.
    Giovannini M; Bories E; Monges G; Pesenti C; Caillol F; Delpero JR
    Surg Endosc; 2011 Jul; 25(7):2247-53. PubMed ID: 21424206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary brush cytology in the assessment of biliary strictures at a tertiary center in Iran.
    Mohammad Alizadeh AH; Mousavi M; Salehi B; Molaei M; Khodadoostan M; Afzali ES; Dadvar Z; Mirsattari D; Aghdaei HA; Lahmi F; Zali MR
    Asian Pac J Cancer Prev; 2011; 12(10):2793-6. PubMed ID: 22320994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CA19-9 antigen levels can distinguish between benign and malignant pancreaticobiliary disease.
    Morris-Stiff G; Teli M; Jardine N; Puntis MC
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):620-6. PubMed ID: 20007080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.